Premier Path Wealth Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Hold |
40,000
| – | – | 0.02% | 385 |
|
|
2025
Q1 | $140K | Hold |
40,000
| – | – | 0.02% | 369 |
|
|
2024
Q4 | $131K | Hold |
40,000
| – | – | 0.02% | 369 |
|
|
2024
Q3 | $154K | Buy |
40,000
+4,000
| +11% | +$15.4K | 0.02% | 361 |
|
|
2024
Q2 | $111K | Buy |
36,000
+5,500
| +18% | +$17K | 0.02% | 366 |
|
|
2024
Q1 | $78.7K | Buy |
30,500
+8,300
| +37% | +$21.4K | 0.01% | 341 |
|
|
2023
Q4 | $55.5K | Buy |
+22,200
| New | +$55.5K | 0.01% | 332 |
|